Expression and regulation of corticotropin-releasing factor receptor type 2β in developing and mature mouse skeletal muscle

Molecular Endocrinology

Volumn 25, Issue 1, 2011, Pages 157-169

  Kuperman, Yael ^a   Issler, Orna ^a   Vaughan, Joan ^b   Bilezikjian, Louise ^b   Vale, Wylie ^b   Chen, Alon ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; CYCLIC AMP; INSULIN; LUCIFERASE; MYOCYTE ENHANCER FACTOR 2; MYOD1 PROTEIN; MYOGENIN; RETINOL BINDING PROTEIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM MOBILIZATION; CHRONIC STRESS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA FLANKING REGION; ENZYME ASSAY; GENE EXPRESSION; GENE FUSION; GENETIC TRANSCRIPTION; GENOME; HORMONAL REGULATION; INSULIN RESISTANCE; LIPID DIET; MALE; MENTAL STRESS; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE TISSUE; MYOBLAST; MYOTUBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYSIOLOGICAL STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBONUCLEASE PROTECTION ASSAY; SKELETAL MUSCLE;

5' FLANKING REGION; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MUTANT PROTEINS; MYOBLASTS; MYOGENIC REGULATORY FACTORS; PROMOTER REGIONS, GENETIC; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RETINOL-BINDING PROTEINS, PLASMA; RNA, MESSENGER; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; UP-REGULATION;

MUS;

EID: 78650868297     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2010-0308     Document Type: Article

References (67)

1. Petersen KF, Shulman GI 2002 Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am J Cardiol 90: 11G-18G
2. Petersen KF, Dufour S, Savage DB, Bilz S, Solomon G, Yonemitsu S, Cline GW, Befroy D, Zemany L, Kahn BB, Papademetris X, Rothman DL, Shulman GI 2007 The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci USA 104: 12587-12594
3. Shulman GI 2004 Unraveling the cellular mechanism of insulin resistance in humans: New insights from magnetic resonance spectroscopy. Physiology (Bethesda) 19: 183-190
4. Brown MR, Fisher LA, Spiess J, Rivier C, Rivier J, Vale W 1982 Corticotropin-releasing factor: Actions on the sympathetic nervous system and metabolism. Endocrinology 111: 928-931
5. Dallman MF, Akana SF, Strack AM, Hanson ES, Sebastian RJ 1995 The neural network that regulates energy balance is responsive to glucocorticoids and insulin and also regulatesHPAaxis responsivity at a site proximal to CRF neurons. Ann NY Acad Sci 771: 730-742
6. Bale TL, Anderson KR, Roberts AJ, Lee KF, Nagy TR, Vale WW 2003 Corticotropin-releasing factor receptor-2-deficient mice display abnormal homeostatic responses to challenges of increased dietary fat and cold. Endocrinology 144: 2580-2587
7. Carlin KM, Vale WW, Bale TL 2006 Vital functions of corticotropin- releasing factor (CRF) pathways in maintenance and regulation of energy homeostasis. Proc Natl Acad Sci USA 103: 3462-3467
8. Chen A, Brar B, Choi CS, Rousso D, Vaughan J, Kuperman Y, Kim SN, Donaldson C, Smith SM, Jamieson P, Li C, Nagy TR, Shulman GI, Lee KF, ValeW2006 Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle. Proc Natl Acad Sci USA 103: 16580-16585
9. Kuperman Y, Chen A 2008 Urocortins: Emerging metabolic and energy homeostasis perspectives. Trends Endocrinol Metab 19: 122-129
10. Huising MO, van der Meulen T, Vaughan JM, Matsumoto M, Donaldson CJ, Park H, Billestrup N, Vale WW 2010 CRFR1 is expressed on pancreatic β cells, promotes β cell proliferation, and potentiates insulin secretion in a glucose-dependent manner. Proc Natl Acad Sci USA 107: 912-917
11. Kuperman Y, Issler O, Regev L, Musseri I, Navon I, Neufeld-Cohen A, Gil S, Chen A 2010 Perifornical urocortin-3 mediates the link between stress-induced anxiety and energy homeostasis. Proc Natl Acad Sci USA 107: 8393-8398
12. Vita N, Laurent P, Lefort S, Chalon P, Lelias JM, Kaghad M, Le Fur G, Caput D, Ferrara P 1993 Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors. FEBS Lett 335: 1-5
13. Chen R, Lewis KA, Perrin MH, ValeWW1993 Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 90: 8967-8971
14. Chang CP, Pearse II RV, O'Connell S, Rosenfeld MG 1993 Identification of a seven transmembrane helix receptor for corticotropinreleasing factor and sauvagine in mammalian brain. Neuron 11: 1187-1195
15. Stenzel P, Kesterson R, Yeung W, Cone RD, Rittenberg MB, Stenzel-Poore MP 1995 Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. Mol Endocrinol 9: 637-645
16. Kishimoto T, Pearse II RV, Lin CR, RosenfeldMG1995 A sauvagine/ corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci USA 92: 1108-1112
17. Perrin M, Donaldson C, Chen R, Blount A, Berggren T, Bilezikjian L, Sawchenko P, Vale W 1995 Identification of a second corticotropin- releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci USA 92: 2969-2973
18. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EB, Oltersdorf T 1995 Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 92: 836-840
19. Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, Prins GS, Perrin M, Vale W, Sawchenko PE 2000 Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428: 191-212
20. Chen A, Perrin M, Brar B, Li C, Jamieson P, Digruccio M, Lewis K, Vale W 2005 Mouse corticotropin-releasing factor receptor type 2alpha gene: Isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids. Mol Endocrinol 19: 441-458
21. Lovenberg TW, Chalmers DT, Liu C, De Souza EB 1995 CRF2 α and CRF2 β receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 136: 4139-4142
22. Sztainberg Y, Kuperman Y, Issler O, Gil S, Vaughan J, Rivier J, Vale W, Chen A 2009 A novel corticotropin-releasing factor receptor splice variant exhibits dominant negative activity: A putative link to stress-induced heart disease. FASEB J 23: 2186-2196
23. Chen A, Blount A, Vaughan J, Brar B, Vale W 2004 Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: Localization, basal expression in corticotropin-releasing factor receptor (CRFR) 1- and CRFR2-null mice, and regulation by glucocorticoids. Endocrinology 145: 2445-2457
24. Hall JE, Kaczor JJ, Hettinga BP, Isfort RJ, Tarnopolsky MA 2007 Effects of a CRF2R agonist and exercise on mdx and wildtype skeletal muscle. Muscle Nerve 36: 336-341
25. Hinkle RT, Donnelly E, Cody DB, Bauer MB, Isfort RJ 2003 Urocortin II treatment reduces skeletal muscle mass and function loss during atrophy and increases nonatrophying skeletal muscle mass and function. Endocrinology 144: 4939-4946
26. Brar BK, Jonassen AK, Egorina EM, Chen A, Negro A, Perrin MH, Mjos OD, Latchman DS, Lee KF, Vale W 2004 Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: An essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart. Endocrinology 145: 24-35; discussion 21-23
27. Makino S, Asaba K, Takao T, Hashimoto K 1998 Type 2 corticotropin- releasing hormone receptor mRNA expression in the heart in hypertensive rats. Life Sci 62: 515-523
28. Makino S, Nishiyama M, Asaba K, Gold PW, Hashimoto K 1998 Altered expression of type 2 CRH receptor mRNA in the VMH by glucocorticoids and starvation. Am J Physiol 275: R1138-R1145
29. Makino S, Asaba K, Nishiyama M, Hashimoto K 1999 Decreased type 2 corticotropin-releasing hormone receptor mRNA expression in the ventromedial hypothalamus during repeated immobilization stress. Neuroendocrinology 70: 160-167
30. Nishiyama M, Makino S, Asaba K, Hashimoto K 1999 Leptin effects on the expression of type-2 CRH receptor mRNA in the ventromedial hypothalamus in the rat. J Neuroendocrinol 11: 307-314
31. Eghbal-Ahmadi M, Avishai-Eliner S, Hatalski CG, Baram TZ 1999 Differential regulation of the expression of corticotropin-releasing factor receptor type 2 (CRF2) in hypothalamus and amygdala of the immature rat by sensory input and food intake. J Neurosci 19: 3982-3991
32. Kageyama K, Gaudriault GE, Bradbury MJ, Vale WW 2000 Regulation of corticotropin-releasing factor receptor type 2 β messenger ribonucleic acid in the rat cardiovascular system by urocortin, glucocorticoids, and cytokines. Endocrinology 141: 2285-2293
33. Kageyama K, Gaudriault GE, Suda T, Vale WW 2003 Regulation of corticotropin-releasing factor receptor type 2β mRNA via cyclic AMP pathway in A7r5 aortic smooth muscle cells. Cell Signal 15: 17-25
34. Coste SC, Heldwein KA, Stevens SL, Tobar-Dupres E, Stenzel- Poore MP 2001 IL-1α and TNFα down-regulate CRH receptor-2 mRNA expression in the mouse heart. Endocrinology 142: 3537-3545
35. Pournajafi-Nazarloo H, Partoo L, Sanzenbacher L, Azizi F, Carter CS 2007 Modulation of corticotropin-releasing hormone type 2 receptor and urocortin 1 and urocortin 2 mRNA expression in the cardiovascular system of prairie voles following acute or chronic stress. Neuroendocrinology 86: 17-25
36. Biressi S, Molinaro M, Cossu G 2007 Cellular heterogeneity during vertebrate skeletal muscle development. Dev Biol 308: 281-293
37. Puri PL, Bhakta K, Wood LD, Costanzo A, Zhu J, Wang JY 2002 A myogenic differentiation checkpoint activated by genotoxic stress. Nat Genet 32: 585-593
38. Kislinger T, Gramolini AO, Pan Y, Rahman K, MacLennan DH, Emili A 2005 Proteome dynamics during C2C12 myoblast differentiation. Mol Cell Proteomics 4: 887-901
39. Puri PL, Sartorelli V 2000 Regulation of muscle regulatory factors by DNA-binding, interacting proteins, and post-transcriptional modifications. J Cell Physiol 185: 155-173
40. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WW, Sawchenko PE 2001 Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 98: 2843-2848
41. Hsu SY, Hsueh AJ 2001 Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 7: 605-611
42. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW 2001 Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 98: 7570-7575
43. Yu YT, Breitbart RE, Smoot LB, Lee Y, Mahdavi V, Nadal-Ginard B 1992 Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. Genes Dev 6: 1783-1798
44. Graham TE, Yang Q, Blüher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB 2006 Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354: 2552-2563
45. Samuelsson S, Lange JS, Hinkle RT, Tarnopolsky M, Isfort RJ 2004 Corticotropin-releasing factor 2 receptor localization in skeletal muscle. J Histochem Cytochem 52: 967-977
46. Buckingham M, Bajard L, Chang T, Daubas P, Hadchouel J, Meilhac S, Montarras D, Rocancourt D, Relaix F 2003 The formation of skeletal muscle: From somite to limb. J Anat 202: 59-68
47. Grammatopoulos D, Dai Y, Chen J, Karteris E, Papadopoulou N, Easton AJ, HillhouseEW1998 Human corticotropin-releasing hormone receptor: Differences in subtype expression between pregnant and nonpregnant myometria. J Clin Endocrinol Metab 83: 2539-2544
48. Heldwein KA, Duncan JE, Stenzel P, Rittenberg MB, Stenzel-Poore MP 1997 Endotoxin regulates corticotropin-releasing hormone receptor 2 in heart and skeletal muscle. Mol Cell Endocrinol 131: 167-172
49. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, et al. 1995 Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378: 287-292
50. Bale TL, Vale WW 2004 CRF and CRF receptors: Role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44: 525-557
51. Perrin MH, Vale WW 1999 Corticotropin releasing factor receptors and their ligand family. Ann NY Acad Sci 885: 312-328
52. Guérineau N, Corcuff JB, Tabarin A, Mollard P 1991 Spontaneous and corticotropin-releasing factor-induced cytosolic calcium transients in corticotrophs. Endocrinology 129: 409-420
53. Kuryshev YA, Childs GV, Ritchie AK 1996 Corticotropin-releasing hormone stimulates Ca2+ entry through L- and P-type Ca2+ channels in rat corticotropes. Endocrinology 137: 2269-2277
54. Hauger RL, Olivares-Reyes JA, Braun S, Catt KJ, Dautzenberg FM 2003 Mediation of corticotropin releasing factor type 1 receptor phosphorylation and desensitization by protein kinase C: A possible role in stress adaptation. J Pharmacol Exp Ther 306: 794-803
55. Fazal N, Slominski A, Choudhry MA, Wei ET, Sayeed MM 1998 Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells. FEBS Lett 435: 187-190
56. Kyrou I, Tsigos C 2007 Stress mechanisms and metabolic complications. Horm Metab Res 39: 430-438
57. James WP, Rigby N, Leach R 2006 Obesity and the metabolic syndrome: The stress on society. Ann NY Acad Sci 1083: 1-10
58. Münzberg H, Myers Jr MG 2005 Molecular and anatomical determinants of central leptin resistance. Nat Neurosci 8: 566-570
59. Liu YL, Emilsson V, Cawthorne MA 1997 Leptin inhibits glycogen synthesis in the isolated soleus muscle of obese (ob/ob) mice. FEBS Lett 411: 351-355
60. Lu XY, Kim CS, Frazer A, ZhangW2006 Leptin: A potential novel antidepressant. Proc Natl Acad Sci USA 103: 1593-1598
61. Dallman MF, Pecoraro N, Akana SF, La Fleur SE, Gomez F, Houshyar H, Bell ME, Bhatnagar S, Laugero KD, Manalo S 2003 Chronic stress and obesity: A new view of "comfort food." Proc Natl Acad Sci USA 100: 11696-11701
62. Dallman MF, Akana SF, Strack AM, Scribner KS, Pecoraro N, La Fleur SE, Houshyar H, Gomez F 2004 Chronic stress-induced effects of corticosterone on brain: Direct and indirect. Ann NY Acad Sci 1018: 141-150
63. Ulrich-Lai YM, Herman JP 2009 Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci 10: 397-409
64. Blaner WS 1989 Retinol-binding protein: The serum transport protein for vitamin A. Endocr Rev 10: 308-316
65. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB 2005 Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436: 356-362
66. Haider DG, Schindler K, Prager G, Bohdjalian A, Luger A, Wolzt M, Ludvik B 2007 Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab 92: 1168-1171
67. McDermott DH, Fong AM, Yang Q, Sechler JM, Cupples LA, Merrell MN, Wilson PW, D'Agostino RB, O'Donnell CJ, Patel DD, Murphy PM 2003 Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J Clin Invest 111: 1241-1250